WeHand-Bio

Beijing, China · Founded 2010 · In IPO Registration

Developer and manufacturer of first-in-class natural drug innovations and advanced drug delivery systems designed for the treatment of complex metabolic disorders, malignant tumors, and… WeHand-Bio is based in Beijing, China and was founded in 2010. Its last reported valuation was $567 million in Sep 2025. It has raised $162 million.

Last reported valuation
$566.6M
Oct 2026
Priced at
—
Total raised
$162.0M
Last round
—

Who backs WeHand-Bio?

10 investors
InvestorType
Cowin CapitalVenture capital
Shun Xi FundPE / buyout
Lapam CapitalVenture capital
Zero2IPO Venture CapitalOther
Beishang Capital Management (Beijing)Other
Hangzhou Wenyi Investment Management Partnership—
Longshine Investment—
Power Capital—
Shanghai Tianzi Investment Management—
Zhong He Yuan Liang—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

WeHand-Bio investors

10 investors are on record for WeHand-Bio, including Cowin Capital, Shun Xi Fund, Lapam Capital and Zero2IPO Venture Capital.

Free account
More of WeHand-Bio with a free account
  • ·Watch WeHand-Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like WeHand-Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View